Research Article
Screening Patterns of Nonalcoholic Fatty Liver Disease in Children with Obesity in Canadian Primary Care: A Cross-Sectional Study
Table 3
Patients with suspected NAFLD.
| | Characteristics | Total suspected NAFLD n (%) (N = 1046) |
| | Age, years | | | 9–12 | 189 (18.1) | | 13–18 | 857 (81.9) |
| | Sex, % male | 542 (51.8) |
| | Location | | | Rural | 246 (24.0) | | Urban | 781 (76.0) | | Missing | 19 |
| | BMI, percentile | | | ≥85th (underweight to normal) | 7 (0.67) | | 86th–94th (overweight) | 4 (0.38) | | ≥95th–<99th (obese) | 667 (63.8) | | ≥99th (severe obesity) | 363 (34.7) | | Missing | 5 |
| | ALT (n = 1021) | | | Median ALT | 31 (18)† | | ALT >40 | 335 (32.3) | | ALT >80 | 82 (7.8) |
| | Health conditions | | | Diabetes | 59 (5.64) | | Hypertension | 95 (9.1) | | Dyslipidemia | 179 (17.1) | | ADHD | 179 (17.1) | | Depression | 239 (22.9) | | PCOS | 18 (1.7) | | Sleep apnea | 9 (0.86) |
| | Medications | | | Antipsychotics | 98 (9.4) | | Anxiolytics | 77 (7.36) | | Antidepressants | 278 (26.6) | | Psychostimulants | 167 (16.0) | | Antihypertensives | 55 (5.3) | | Antidiabetics | 42 (4.0) |
| | Prior primary healthcare utilization over 1 year | 4 (6)† |
| | Prior specialist referral | | | Gastroenterology | 34 (3.25%) | | Pediatrics | 231 (22.1%) | | Endocrinology | 53 (5.07%) | | Weight clinic/dietician | 2 (0.19%) |
|
|
†Reported as median (interquartile range); BMI, body mass index; ALT, alanine transaminase; ADHD, attention deficit hyperactivity disorder; PCOS, polycystic ovarian syndrome.
|
